170 related articles for article (PubMed ID: 16798006)
1. Hearing loss and cochlear damage in experimental pneumococcal meningitis, with special reference to the role of neutrophil granulocytes.
Brandt CT; Cayé-Thomasen P; Lund SP; Worsøe L; Ostergaard C; Frimodt-Møller N; Espersen F; Thomsen J; Lundgren JD
Neurobiol Dis; 2006 Aug; 23(2):300-11. PubMed ID: 16798006
[TBL] [Abstract][Full Text] [Related]
2. Systemic steroid reduces long-term hearing loss in experimental pneumococcal meningitis.
Worsøe L; Brandt CT; Lund SP; Østergaard C; Thomsen J; Cayé-Thomasen P
Laryngoscope; 2010 Sep; 120(9):1872-9. PubMed ID: 20717948
[TBL] [Abstract][Full Text] [Related]
3. Intratympanic steroid prevents long-term spiral ganglion neuron loss in experimental meningitis.
Worsøe L; Brandt CT; Lund SP; Ostergaard C; Thomsen J; Cayé-Thomasen P
Otol Neurotol; 2010 Apr; 31(3):394-403. PubMed ID: 20147868
[TBL] [Abstract][Full Text] [Related]
4. MyD88-dependent immune response contributes to hearing loss in experimental pneumococcal meningitis.
Klein M; Schmidt C; Kastenbauer S; Paul R; Kirschning CJ; Wagner H; Popp B; Pfister HW; Koedel U
J Infect Dis; 2007 Apr; 195(8):1189-93. PubMed ID: 17357057
[TBL] [Abstract][Full Text] [Related]
5. Time course of hearing loss in an animal model of pneumococcal meningitis.
Kesser BW; Hashisaki GT; Spindel JH; Ruth RA; Scheld WM
Otolaryngol Head Neck Surg; 1999 May; 120(5):628-37. PubMed ID: 10229585
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of post-meningitic cochlear injury with cerebrospinal fluid irrigation.
Yeung AH; Tinling SP; Brodie HA
Otolaryngol Head Neck Surg; 2006 Feb; 134(2):214-24. PubMed ID: 16455367
[TBL] [Abstract][Full Text] [Related]
7. Otoprotective effects of dexamethasone in the management of pneumococcal meningitis: an animal study.
Kim HH; Addison J; Suh E; Trune DR; Richter CP
Laryngoscope; 2007 Jul; 117(7):1209-15. PubMed ID: 17603319
[TBL] [Abstract][Full Text] [Related]
8. Meningitis-associated hearing loss: protection by adjunctive antioxidant therapy.
Klein M; Koedel U; Pfister HW; Kastenbauer S
Ann Neurol; 2003 Oct; 54(4):451-8. PubMed ID: 14520656
[TBL] [Abstract][Full Text] [Related]
9. Routes, dynamics, and correlates of cochlear inflammation in terminal and recovering experimental meningitis.
Cayé-Thomasen P; Worsøe L; Brandt CT; Miyazaki H; Ostergaard C; Frimodt-Møller N; Thomsen J
Laryngoscope; 2009 Aug; 119(8):1560-70. PubMed ID: 19504554
[TBL] [Abstract][Full Text] [Related]
10. Experimental studies of pneumococcal meningitis.
Brandt CT
Dan Med Bull; 2010 Jan; 57(1):B4119. PubMed ID: 20175949
[TBL] [Abstract][Full Text] [Related]
11. Nitrogen and oxygen molecules in meningitis-associated labyrinthitis and hearing impairment.
Klein M; Koedel U; Kastenbauer S; Pfister HW
Infection; 2008 Feb; 36(1):2-14. PubMed ID: 18084715
[TBL] [Abstract][Full Text] [Related]
12. Blocking of leukocyte accumulation in the cerebrospinal fluid augments bacteremia and increases lethality in experimental pneumococcal meningitis.
Brandt CT; Lundgren JD; Frimodt-Møller N; Christensen T; Benfield T; Espersen F; Hougaard DM; Ostergaard C
J Neuroimmunol; 2005 Sep; 166(1-2):126-31. PubMed ID: 15982752
[TBL] [Abstract][Full Text] [Related]
13. Short-term rifampicin pretreatment reduces inflammation and neuronal cell death in a rabbit model of bacterial meningitis.
Spreer A; Lugert R; Stoltefaut V; Hoecht A; Eiffert H; Nau R
Crit Care Med; 2009 Jul; 37(7):2253-8. PubMed ID: 19487938
[TBL] [Abstract][Full Text] [Related]
14. Prevention of hearing loss in experimental pneumococcal meningitis by administration of dexamethasone and ketorolac.
Rappaport JM; Bhatt SM; Burkard RF; Merchant SN; Nadol JB
J Infect Dis; 1999 Jan; 179(1):264-8. PubMed ID: 9841852
[TBL] [Abstract][Full Text] [Related]
15. The Severity of Infection Determines the Localization of Damage and Extent of Sensorineural Hearing Loss in Experimental Pneumococcal Meningitis.
Perny M; Roccio M; Grandgirard D; Solyga M; Senn P; Leib SL
J Neurosci; 2016 Jul; 36(29):7740-9. PubMed ID: 27445150
[TBL] [Abstract][Full Text] [Related]
16. Caspase inhibitor facilitates recovery of hearing by protecting the cochlear lateral wall from acute cochlear mitochondrial dysfunction.
Mizutari K; Matsunaga T; Kamiya K; Fujinami Y; Fujii M; Ogawa K
J Neurosci Res; 2008 Jan; 86(1):215-22. PubMed ID: 17722114
[TBL] [Abstract][Full Text] [Related]
17. Metformin mediates neuroprotection and attenuates hearing loss in experimental pneumococcal meningitis.
Muri L; Le ND; Zemp J; Grandgirard D; Leib SL
J Neuroinflammation; 2019 Jul; 16(1):156. PubMed ID: 31351490
[TBL] [Abstract][Full Text] [Related]
18. Limited efficacy of adjuvant therapy with dexamethasone in preventing hearing loss due to experimental pneumococcal meningitis in the infant rat.
Coimbra RS; Loquet G; Leib SL
Pediatr Res; 2007 Sep; 62(3):291-4. PubMed ID: 17622952
[TBL] [Abstract][Full Text] [Related]
19. Diameter of the cochlear nerve in endolymphatic hydrops: implications for the etiology of hearing loss in Ménière's disease.
Megerian CA
Laryngoscope; 2005 Sep; 115(9):1525-35. PubMed ID: 16148690
[TBL] [Abstract][Full Text] [Related]
20. Auditory development in progressive motor neuronopathy mouse mutants.
Volkenstein S; Brors D; Hansen S; Berend A; Mlynski R; Aletsee C; Dazert S
Neurosci Lett; 2009 Nov; 465(1):45-9. PubMed ID: 19735697
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
